What is BioCryst Pharmaceuticals's exercise of warrants?

BioCryst Pharmaceuticals (BCRX) reported exercise of warrants of $0 in Q4 2023.

What does exercise of warrants mean?

The total value received from the exercise of warrants, representing the conversion of derivative instruments into common equity. This metric highlights potential capital inflows from warrant holders and the resulting impact on the company's total share count.

BioCryst Pharmaceuticals BCRX Exercise of warrants

Exercise of warrants at other companies

KEE

Keel Infrastructure Corp. Common StockKEEL

15.2M+197%

Eos Energy Enterprises, Inc.EOSE

$3.28M-53.3%

DJT

Trump Media & Technology GroupDJT

$80.5K-57.5%

OneSpaWorld Holdings LimitedOSW

$0—

Noble CorporationNE

$2.57M+6,661%

NextNavNN

$13K-97.5%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept bcrx:StockIssuedDuringPeriodValueExerciseOfWarrants.

The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's exercise of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's exercise of warrants?: BioCryst Pharmaceuticals (BCRX) reported exercise of warrants of $0 in Q4 2023.
What does exercise of warrants mean?: The total value received from the exercise of warrants, representing the conversion of derivative instruments into common equity. This metric highlights potential capital inflows from warrant holders and the resulting impact on the company's total share count.